We serve Chemical Name:4-Bromo-2-chloro-3-fluoropyridine CAS:1211526-56-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-2-chloro-3-fluoropyridine
CAS.NO:1211526-56-5
Synonyms:4-Bromo-2-chloro-3-fluoropyridine
Molecular Formula:C5H2BrClFN
Molecular Weight:210.43100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:12.89000
Exact Mass:208.90400
LogP:2.63660
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-Bromo-2-chloro-3-fluoropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromo-2-chloro-3-fluoropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-2-chloro-3-fluoropyridine Use and application,4-Bromo-2-chloro-3-fluoropyridine technical grade,usp/ep/jp grade.
Related News: This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. 4-((3-bromo-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino)-N-(2-(dimethylamino)ethyl)benzenesulfonamide manufacturers The publication of the R&D People and Culture Strategy comes alongside the launch of the Innovation Strategy, which aims to make the UK a global hub for innovation and increase business investment in R&D. N-Hippuroyl-N’-DL-phenylalanyl-hydrazin suppliers UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. 4-(1-Propyl-piperidin-3-yl)-phenol; hydrobromide vendor & factory In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April.,In the US, avalglucosidase alfa saw its PDUFA date pushed back by three months, from May 18 to Aug. 18, according to a Sanofi investor presentation in April.
